Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular autologous platelet gel to inhibit erosions in rheumatoid arthritis
2006-005391-40Phase 2Terminated
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Jun 2007
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous platelet-rich plasma in rheumatoid arthritis (RA) (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoints: Repair of single rheumatoid erosions and Reduction of global erosions. Started Jun 2007; status: terminated.
02
Drugs
autologous platelet-rich plasma
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-005391-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005391-40.